Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion type Assertion NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_head.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion description "[Analysis of various types of tumors shows that TGFBR1*6A carriers are at increased risk of developing breast cancer (OR, 1.48; 95% CI, 1.11 to 1.96), hematological malignancies (OR, 1.70; 95% CI, 1.13 to 2.54), and ovarian cancer (OR, 1.53; 95% CI, 1.07 to 2.17).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_provenance.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion evidence source_evidence_literature NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_provenance.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion SIO_000772 12947057 NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_provenance.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion wasDerivedFrom befree-20140225 NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_provenance.
- NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_assertion wasGeneratedBy ECO_0000203 NP718915.RAt7Isqc9xV68eGGN7bCxEQtH4lQ2ndsEqOeqStW_cys4130_provenance.